Differential effects of amrinone and milrinone upon myocardial inflammatory signaling

Circulation

Volumn 106, Issue 13 SUPPL., 2002, Pages

  Chanani, Nikhil K ^a   Cowan, Douglas B ^a   Takeuchi, Koh ^a   Poutias, Dimitrios N ^a   Garcia, Lina M ^a   Del Nido, Pedro J ^a   McGowan Jr , Francis X ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Cyclooxygenase; Cytokines; Inflammation; Inotropic agents; Nitric oxide synthase; Phosphodiesterase inhibitor

Indexed keywords

AMRINONE; CYCLIC AMP; CYCLOOXYGENASE 2; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPROTEIN; MILRINONE; NITRIC OXIDE SYNTHASE; PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARDIOPULMONARY BYPASS; CELL MEMBRANE PERMEABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ELECTROPHORETIC MOBILITY; GENE EXPRESSION REGULATION; HEART FAILURE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; INFLAMMATION; MYOCARDIAL DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE;

AMRINONE; ANIMALS; ANTI-INFLAMMATORY AGENTS; CARDIOTONIC AGENTS; CELL LINE; CELLS, CULTURED; CYCLOOXYGENASE 2; CYTOKINES; ENDOTHELIUM, VASCULAR; HEART; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; ISOENZYMES; MACROPHAGES; MICROCIRCULATION; MILRINONE; MYOCARDIUM; NF-KAPPA B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHODIESTERASE INHIBITORS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 0037167645     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1993;55:552-559.
2. Kirklin JK. Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass. Ann Thorac Surg. 1991;51:529-531.
3. Butler J, Chong GL, Balgerie RJ, et al. Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation. Ann Thorac Surg. 1992;53:833-838.
4. Matsumori A, Sasayama S. Immunomodulating agents for the management of heart failure with myocarditis and cardiomyopathy: lessons from animal experiments. Eur Heart J. 1995;16(suppl):140-143.
5. Matsui S, Matsumori A, Matoba Y, et al. Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone: suppression of natural killer cell activity and tumor necrosis factor-alpha production. J Clin Invest. 1994;1212-1217.
6. Bergman MR, Holycross BJ. Pharmacologic modulation of tumor necrosis factor-alpha production by phosphodiesterase inhibitors. J Pharmacol Exp Therap. 1996;279:247-254.
7. Giroir BP, Beutler B. Effect of amrinone on tumor necrosis factor production in endotoxic shock. Circ Shock. 1992;36:200-207.
8. Levine B, Kalman J, Mayer L, et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure, N Engl J Med. 1990;323:236-241.
9. Takeuchi K, del Nido PJ, Ibrahim AE, et al. Vesnarinone and amrinone reduce the systemic inflammatory response syndrome. J Thorac Cardiovasc Surg. 1999;117:375-382.
10. Takeuchi K, del Nido PJ, Poutias DN, et al. Vesnarinone restores contractility and calcium handling in early endotoxemia. Circulation. 2000; 102(suppl III):III-365-III-369.
11. Cowan DB, Poutias DN, del Nido PJ, et al. CD14-independent activation of cardiomyocyte signal transduction by bacterial endotoxin. Am J Physiol. 2000;279:H619-H629.
12. Ausubel, S. M., Brent R, Kingston RE, et al. Short Protocols in Molecular Biology. New York: John Wiley and Sons; 1995.
13. Cowan DB, Lye SJ, Langille BL. Regulation of vascular connexin43 gene expression by mechanical loads. Circ Res. 1998;82:786-793.
14. Zund Z, Uezono S, Stahl GL, et al. Hypoxia enhances induction of endothelial ICAM-1: role for metabolic acidosis and proteasomes. Am J Physiol. 1997;273:C1571-C1580.
15. Luss H., Watkins SC., Freeswick PD, et al. Characterization of inducible nitric oxide synthase expression in endotoxemic rat cardiomyocytes in vivo and following cytokine exposure in vitro. J Mol Cell Cardiol. 1995;27:2015-2029.
16. Andrews NC, Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucl Acids Res. 1991;19:2499.
17. Cowan DB, Weisel RD, Williams WG, et al. Identification of oxygen responsive elements in the 5′-flanking region of the human glutathione peroxidase gene. J Biol Chem. 1993;268:26904-26910.
18. Herskowitz A, Choi S, Ansari AA, et al. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol. 1995;146:419-428.
19. Badger AM, Olivera DL, Esser KM. Beneficial effects of the phosphodiesterase inhibitors BRL 61063, pentoxifylline, and rolipram in a murine model of endotoxin shock. Circ Shock. 1994;44:188-195.
20. Essayan DM. Cyclic nucleotide phospodiesterases. J Allergy Clin Immunol. 2001;108:671-680.
21. Valen G, Yan ZQ, Hansson GK. Nuclear factor kappa-B and the heart. J Am Coll Cardiol. 2001;38:307-314.
22. Rice GC, Brown P, Nelson RJ. Protection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid. Proc Natl Acad Sci USA. 1994;91:3857-3861.
23. Harbrecht BG, Stadler J, Demetris AJ, Simmons RL, Billiar TR. Nitric oxide and prostaglandins interact to prevent hepatic damage during murine endotoxemia. Am J Physiol. 1994;266:G1004-G1010.
24. Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 1998;38:97-120.
25. von Knethen A, Brune B. Cyclooxygenase-2: an essential regulator of NO-mediated apoptosis. FASEB J. 1997;11:887-895.
26. Watanabe T, Satoh H, Togoh M, et al. Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells. J Cell Physiol. 1996;169:401-409.
27. Camitta MGW, Gabel SA, Chulada P, et al. Cyoclooxygenase-1 and -2 knockout mice demonstrate increased cardiac ischemia/reperfusion injury but are protected by acute preconditioning. Circ Res. 2001;104:2453-2458.
28. Adderley SR, Fitzgerald DJ. Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases1/2-mediated induction of cyclooxygenase-2. J Biol Chem. 1999;274:5038-5046.
29. Dinchuk JE, Car BD, Focht RJ, et al. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase-2. Nature. 1995; 378:406-409.
30. Camacho M, Lopez-Belmonte J, Vila L. Rate of prostanoids released by endothelial cells depends on cyclooxygenase-2 expression and prostaglandin I synthase activity. Circ Res. 1998;83:353-365.